Multicorp Intl Correlations

MCIC Stock  USD 0.0001  0.00  0.00%   
The current 90-days correlation between Multicorp Intl and Nexien Biopharma is 0.01 (i.e., Significant diversification). The correlation of Multicorp Intl is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Multicorp Intl Correlation With Market

Average diversification

The correlation between Multicorp Intl and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Multicorp Intl and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Multicorp Intl could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Multicorp Intl when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Multicorp Intl - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Multicorp Intl to buy it.

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

XTXXFNXEN
AQSZFNXEN
XTXXFAQSZF
RMRKAQSZF
XTXXFNEPTF
NEPTFNXEN
  

High negative correlations

RMRKNEPTF
RMRKDVLP
AQSZFNEPTF
RMRKXTXXF
RMRKNXEN
TSTSEAPH

Risk-Adjusted Indicators

There is a big difference between Multicorp Pink Sheet performing well and Multicorp Intl Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Multicorp Intl's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
NXEN  5.74 (2.81) 0.00  7.16  0.00 
 0.00 
 105.56 
NEPTF  9.78  2.24  0.00 (0.33) 0.00 
 0.00 
 399.00 
ACUS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
DVLP  32.30  13.11  0.00  0.77  0.00 
 0.00 
 100.00 
AQSZF  6.96  0.62  0.00 (0.45) 0.00 
 0.00 
 170.51 
XTXXF  4.42 (2.13) 0.00  1.18  0.00 
 0.00 
 96.08 
IVIXF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RMRK  5.21  1.11  0.00 (0.30) 0.00 
 0.00 
 91.67 
EAPH  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TSTS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Multicorp Intl without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Multicorp Intl Corporate Management

Kia MohammadiChief OfficerProfile
David GustafsonInterim OfficerProfile
Ben FriedmanPres DirectorProfile
Paul LisenbyChairman CEOProfile
Tony PlattChief OfficerProfile